Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

ETR/IUI1 stock hub

ETR/IUI1 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/IUI1is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

135.4B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/IUI1

In the news

Latest news · ETR/IUI1

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E41.9

P25 12.3P50 15.7P75 20.2

Trailing P/E52.4

P25 16.4P50 20.9P75 30.4

ROE17.2

P25 -6.7P50 8.5P75 17.2

ROIC21.4

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/IUI1 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	17,021
Employees Change	1,383%
Employees Change Percent	8.84
Enterprise value	EUR 131.7B
Exchange	Deutsche Börse Xetra
Financial currency	USD
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Last refreshed	2026-05-10
Market cap	EUR 135.4B
Price	EUR 381
Price currency	EUR
Rev Per Employee	539,207.76x
Sector	Healthcare
Sic	3845
Symbol	etr/IUI1
Website	https://www.intuitive.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.91%
EV Earnings	50.97x
EV/EBIT	48.1x
EV/EBITDA	39.48x
EV/FCF	53.57x
EV/Sales	14.65x
FCF yield	1.82%
Forward P/E	41.91x
P/B ratio	8.87x
P/E ratio	52.41x
P/S ratio	14.76x
PE Ratio10 Y	61.61x
PE Ratio3 Y	71.02x
PE Ratio5 Y	68.43x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	30.45%
EBITDA Margin	36.72%
FCF margin	26.78%
Gross margin	66.29%
Gross Profit	EUR 6.1B
Gross Profit Growth	19.99%
Gross Profit Growth Q	25.57%
Gross Profit Growth3 Y	17.73%
Gross Profit Growth5 Y	18.32%
Net Income	EUR 2.6B
Net Income Growth	20.31%
Net Income Growth Q	17.63%
Net Income Growth3 Y	31.44%
Net Income Growth5 Y	20.48%
Pretax Margin	33.86%
Profit Margin	28.15%
Profit Per Employee	EUR 151,799
ROA	10.24
Roa5y	8.5
ROCE	17.71
ROE	17.23
Roe5y	14.94
ROIC	21.36
Roic5y	21.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-18.36%
Cagr3y	11.46%
Cagr5y	10.06%
EPS Growth	20.47
EPS Growth Q	18.75
EPS Growth3 Y	31.16
EPS Growth5 Y	20.49
FCF Growth	62.4%
FCF Growth Q	73.89%
FCF Growth3 Y	41.22%
FCF Growth5 Y	16.61%
OCF Growth	23.05%
OCF Growth Q	56.79%
OCF Growth10 Y	14.4%
OCF Growth3 Y	27.04%
OCF Growth5 Y	15.86%
Revenue Growth	21.43x
Revenue Growth Q	22.96x
Revenue Growth3 Y	18.06x
Revenue Growth5 Y	18.38x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.54
Assets	EUR 17.4B
Cash	EUR 3.9B
Current Assets	EUR 7.5B
Current Liabilities	EUR 1.6B
Equity	EUR 15.3B
Liabilities	EUR 2.2B
Long Term Assets	EUR 10B
Long Term Liabilities	EUR 559.8M
Net Cash	EUR 3.9B
Net Cash By Market Cap	EUR 2.89
Net Cash Growth	0.13%
Net Debt EBITDA	EUR -1.16
Net Debt Equity	EUR -0.26
Net Debt FCF	EUR -1.59
Tangible Book Value	EUR 14.5B
Tangible Book Value Per Share	EUR 40.84
WACC	12.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.61
Inventory Turnover	2.04
Net Working Capital	EUR 2.1B
Quick ratio	3.26
Working Capital	EUR 6B
Working Capital Turnover	EUR 1.41

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-18.35%
200-day SMA	427.2
3Y total return	38.47%
50-day SMA	405.6
50-day SMA vs 200-day SMA	50under200
5Y total return	61.5%
All Time High	594.4
All Time High Change	-35.84%
All Time High Date	2025-01-23
All Time Low	178.4
All Time Low Change	113.76%
All Time Low Date	2022-06-16
ATR	8.86
Beta	1.51
Ch YTD	-22.05
High	388.7
High52	516.1
High52 Date	2026-01-07
High52ch	-26.11%
Low	380.8
Low52	364.6
Low52 Date	2025-09-16
Low52ch	4.59%
Ma50ch	-5.98%
Price vs 200-day SMA	-10.74%
RSI	40.95
RSI Monthly	45.39
RSI Weekly	37.52
Sharpe ratio	-0.72x
Sortino ratio	-0.89
Total Return	0.42%
Tr YTD	-22.05
Tr1m	-1.93%
Tr1w	-1.28%
Tr3m	-8.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 2.8B
Operating Income Growth	31.13
Operating Income Growth Q	47.95
Operating Income Growth3 Y	26.69
Operating Income Growth5 Y	22.18
Operating margin	30.45

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	351,968,623%
Shares Insiders	0.52%
Shares Institutions	87.26%
Shares Qo Q	-0.17%
Shares Yo Y	-0.42%
Short Ratio	3.5

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 1.8B
Average Volume	379.25x
Bv Per Share	42.76
CAPEX	EUR -456.6M
Ch1m	-1.93
Ch1w	-1.28
Ch1y	-18.35
Ch3m	-8.23
Ch3y	38.47
Ch5y	61.5
Ch6m	-20.49
Change	-2.28%
Change From Open	-1.57
Close	390.3
Days Gap	-0.72
Depreciation Amortization	562,114,009.8
Dollar Volume	83,515.7
Earnings Date	2026-07-21
EBIT	EUR 2.8B
EBITDA	EUR 3.4B
EPS	EUR 7.14
F Score	5
FCF	EUR 2.5B
FCF EV Yield	1.87x
Financing CF	-3,019,938,600
Fiscal Year End	December
Founded	1,995
Goodwill	519,970,298.4
Graham Number	83.88045
Graham Upside	-78
Income Tax	EUR 506.9M
Investing CF	-400,866,060
Is Primary Listing	0
Last Earnings Date	2026-01-21
Last Report Date	2026-03-31
Last Split Date	2021-10-05
Last Split Type	Forward
Lynch Fair Value	EUR 149
Lynch Upside	-60.92
Ma150	436.1
Ma150ch	-12.55%
Ma20	394
Ma20ch	-3.21%
Net CF	-490,111,230
Next Earnings Date	2026-07-21
Open	387.5
P FCF Ratio	55.09
P OCF Ratio	46.46
Position In Range	7.01
Ppne	4,619,612,179.8
Price Date	2026-05-08
Price EBITDA	EUR 40.18
Ptbv Ratio	9.36
Relative Volume	0.58x
Revenue	9,177,855,330x
SBC By Revenue	7.68x
Share Based Comp	704,681,250
Tax By Revenue	5.52x
Tax Rate	16.31%
Tr6m	-20.49%
Volume	219
Z Score	45.35

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ETR/IUI1 pay a dividend?

Capital-return profile for this ticker.

Performance

ETR/IUI1 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/IUI1?

Insider, institutional, and short-interest positioning.

Institutional ownership

+87.3%

Share of float held by funds and institutions

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ETR/IUI1 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.0

Neutral momentum band

Price vs 200-day MA

-10.7%

50/200-day relationship not available

Beta (5Y)

1.51

More volatile than the market

Sharpe ratio

-0.72

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/IUI1

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/IUI1 stock rating?

etr/IUI1 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/IUI1 analysis?

The full report lives at /stocks/etr/IUI1/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/IUI1?

The latest report frames etr/IUI1 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/IUI1 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.